Athyrium Capital Management
New York, United States · Growth
Their stated focus (public profile)
Athyrium Capital Management is a specialized asset management platform focused on structured investments in the global healthcare and life sciences sectors, including biotechnology, pharmaceuticals, healthcare services, healthcare technology, and medical devices. The firm invests in public and private commercial-stage companies with compelling products and differentiated services, deploying up to $200 million per investment across a wide range of asset classes including private equity, fixed income, royalties, and other structured securities.
Stages: Growth
Sectors: Healthtech, Life sciences, Medtech
Check size: Up to $200 million per investment with ability to flex up opportunistically
On file: 13 partners on record · 40 companies on record
Website: athyrium.com
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Is this your fund? Request a correction or removal.
Search the funds we have on file
Looking for investors? Search the funds we have on file — what they back, where they are, and whether your raise fits. Sign in and Percy matches you to the right ones.
Looking to claim your own fund? Start here →
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Funds closest to this thesis
Ordered by how close each thesis sits to this one.
Is this your fund? Request a correction or removal.